SEC Form 4 · accession 0000904454-17-000452
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kim P. Kamdar
Director · 10% Owner
Period of report
Jun 20, 2017
Accepted (ET)
Jun 22, 2017 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.19 | Jun 20, 2017 | A | 12,450 | A | — | Jun 20, 2027 | Common Stock | 12,450 | 12,450 | D |
Explanation of responses
- F1Subject to the Reporting Person's continuous service to the Issuer, the option vests on the earlier of (i) June 20, 2018, (ii) the day preceding the Issuer's 2018 annual meeting of stockholders, or (iii) immediately prior to a change of control of the Issuer.